
Immunising infants and older people against RSV found to not be cost-effective - HIQA
28/4/2026
0:00
2:54
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.
See omnystudio.com/listener for privacy information.
Altri episodi di "Morning Ireland"



Non perdere nemmeno un episodio di “Morning Ireland”. Iscriviti all'app gratuita GetPodcast.








